跳至主要内容
临床试验/IRCT2014020816524N1
IRCT2014020816524N1已完成2 期

Comparison of the Effect of Alfentanil and Remifentanil on QT Interval in Septoplasty with Local Epinephrine

Vice Chancellor for Research, Shiraz University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Patients with physical status class I -II, based on the classification of the American Society of Anesthesiologists (ASA) and the age up to50 years undergoing septoplasty. Exclusion criteria: the use of any effective drug on QT interval in 14 days before surgery (TCA); beta antagonist, anti-arrhythmic, the calcium channel blocker) ; QTc more than 440 m/s; The existence of branches blocks, arrhythmia (preexitation syndrome) ; Structural heart disease.; electrolyte imbalance; hyper or hypothyroid patients 7. Extreme Obesity BMI 30 >; Diabetic neuropathy; Any non- sinus rhythm in EKG; A history of sensitivity to propofol, egg and soy.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research, Shiraz University of Medical Sciences

相似试验

Effect of Alfentanil and Remifentanil on QT Interval | 临床试验